These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2031512)

  • 1. A phase II study of oral idarubicin (4-demethoxidaunorubicin) in previously untreated elderly patients with non-Hodgkin's lymphoma.
    Errante D; Sorio R; Zagonel V; Carbone A; Monfardini S; Tirelli U
    Am J Clin Oncol; 1991 Jun; 14(3):243-5. PubMed ID: 2031512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma.
    Case DC; Hayes DM; Gerber M; Gams R; Ervin TJ; Dorsk BM
    Cancer Res; 1990 Nov; 50(21):6833-5. PubMed ID: 2208149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.
    Case DC; Gerber MC; Gams RA; Crawford J; Votaw ML; Higano CS; Pruitt BT; Gould J
    Cancer Res; 1992 Jul; 52(14):3871-4. PubMed ID: 1617662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
    Zinzani PL; Pulsoni A; Gentilini P; Visani G; Perrotti A; Molinari AL; Guardigni L; Tani M; Villivà N; Stefoni V; Alinari L; Martelli M; Bonifazi F; Pileri S; Tura S; Baccarani M
    Leuk Lymphoma; 2004 Sep; 45(9):1815-9. PubMed ID: 15223641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial.
    Taylor PR; White JM; Prescott RJ; Angus B; Galloway MJ; Jackson GH; Lessells AM; Lucraft HH; Summerfield GP; Proctor SJ;
    Leuk Lymphoma; 2006 Nov; 47(11):2321-30. PubMed ID: 17107904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.
    Case DC; Gerber MC; Gams RA; Crawford J; Votaw ML; Higano CS; Pruitt BT; Gould J
    Leuk Lymphoma; 1993; 10 Suppl():73-9. PubMed ID: 8481674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral idarubicin in non-Hodgkin's lymphomas.
    Lopez M; Di Lauro L; Papaldo P
    Invest New Drugs; 1986; 4(3):263-7. PubMed ID: 3469170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.
    Morra E; Gargantini L; Nosari A; Barbarano L; Pungolino E; Santoleri L; Bernuzzi P
    Crit Rev Oncol Hematol; 2000 Aug; 35(2):95-100. PubMed ID: 10936466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of oral idarubicin in elderly patients with advanced breast cancer.
    Chevallier B; Monnier A; Metz R; Namer M; Marty M; Roche H; Bastit P; Hurteloup P
    Am J Clin Oncol; 1990 Oct; 13(5):436-9. PubMed ID: 2220664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma.
    Reiser M; Schnell R; Straub G; Borchmann P; Wilhelm M; Ubelacker R; Wörmann B; Münch R; Diehl V; Engert A
    Leuk Lymphoma; 1998 Oct; 31(3-4):359-66. PubMed ID: 9869200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-Hodgkin's lymphoma.
    Zinzani PL; Martelli M; Storti S; Musso M; Cantonetti M; Leone G; Cajozzo A; Papa G; Iannitto E; Perrotti A
    Leuk Lymphoma; 1995 Oct; 19(3-4):329-35. PubMed ID: 8535227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma.
    Salman H; Perez A; Sparano JA; Ratech H; Negassa A; Hopkins U; Villani G; Fuks J; Wiernik PH
    Am J Clin Oncol; 2003 Aug; 26(4):338-43. PubMed ID: 12902881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idarubicin in low-grade non-Hodgkin's lymphomas.
    Zinzani PL
    Haematologica; 1997; 82(5 Suppl):23-4. PubMed ID: 9402750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary treatment of low-grade non-Hodgkin's lymphoma using an all oral anthracycline-containing regimen, chlorambucil, idarubicin, dexamethasone (CID)--a phase II study.
    Taylor PR; Jackson GH; Galloway MJ; Soukop M; Tinegate H; Angus B; Proctor SJ
    Cancer Chemother Pharmacol; 2000; 46(1):63-8. PubMed ID: 10912580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral idarubicin in measurable gastric cancer.
    Abad-Esteve A; Diaz-Rubio E; Jimeno JM; Rosell R; Villar A; Gonzalez-Larriba JL
    Am J Clin Oncol; 1989 Feb; 12(1):14-6. PubMed ID: 2912018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia.
    Gahn B; Brittinger G; Dölken G; Döhner H; Emmerich B; Franke A; Freund M; Huber C; Kuse R; Scholten T; Hiddemann W
    Leuk Lymphoma; 2000 Mar; 37(1-2):169-73. PubMed ID: 10721782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
    McMaster ML; Johnson DH; Greer JP; Wolff SN; Hildreth CR; Greco FA; Hainsworth JD
    Cancer; 1991 Mar; 67(6):1487-92. PubMed ID: 1705861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.
    Gómez H; Mas L; Casanova L; Pen DL; Santillana S; Valdivia S; Otero J; Rodriguez W; Carracedo C; Vallejos C
    J Clin Oncol; 1998 Jul; 16(7):2352-8. PubMed ID: 9667250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas.
    Bocchia M; Bigazzi C; Marconcini S; Forconi F; Marotta G; Algeri R; Lauria F
    Haematologica; 1999 Aug; 84(8):716-20. PubMed ID: 10457407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease.
    Silver RT; Case DC; Wheeler RH; Miller TP; Stein RS; Stuart JJ; Peterson BA; Rivkin SE; Golomb HM; Costanzi
    J Clin Oncol; 1991 May; 9(5):754-61. PubMed ID: 2016617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.